Form 8-K REPLIGEN CORP For: Apr 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Repligen (RGEN) PT Lowered to $940 at Truist Securities
April 29, 2025 4:03 PM EDTTruist Securities analyst Srikripa Devarakonda lowered the price target on Repligen (NASDAQ: RGEN) to $940.00 (from $975.00) while maintaining a Buy rating.
The analyst comments "While near-term investor focus remains on the Eylea tail, REGN continues to deliver growth on top/bottom line... More
Repligen (RGEN) PT Lowered to $914 at Jefferies
April 29, 2025 3:58 PM EDTJefferies analyst Matthew Stanton lowered the price target on Repligen (NASDAQ: RGEN) to $914.00 (from $936.00) while maintaining a Buy rating.
The analyst comments "Bottom line: REGN entered Q1 w/ a fairly negative bias into the print given: 1) we were modeling Eylea to miss HERE given the issues w/ Good Days, its pt assistance... More
Repligen (RGEN) PT Lowered to $190 at JPMorgan, 'All in, we applaud RGEN’s consistent performance during the bioprocessing recovery'
April 29, 2025 2:54 PM EDTJPMorgan analyst Rachel Vatnsdal lowered the price target on Repligen (NASDAQ: RGEN) to $190.00 (from $200.00) while maintaining a Overweight rating.
The analyst comments "Repligen (RGEN) reported a strong top-line and bottom-line 1Q beat while reiterating organic revenue growth for the year. Diving deeper, RGEN revenues of $169M came in above the Street of $164M, reflecting +11% organic growth y/y (vs. Street of +7.9% y/y), leading to adj. EPS of $0.39 (vs. Street of $0.34). RGEN raised its... More
